NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...
New York, NY – October 26, 2023 – Veradermics, a burgeoning biopharmaceutical company, is generating significant excitement...
By Douglas Feil, NBCF Chief Program Officer The burgeoning popularity of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, primarily...
NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...
NEW YORK CITY — In a pivotal moment for the global oncology community, the Breast Cancer Research...
The journey through breast cancer is often depicted as a linear progression: diagnosis, treatment, and recovery. However,...
In the high-stakes world of pharmaceutical research and development, the line between visionary investment and speculative mania...
In a move that underscores the evolving landscape of global pharmaceutical research, Roche has announced a significant...
In a landmark achievement for reproductive science and genomic medicine, researchers at Newcastle University and The Newcastle...
In a paradigm-shifting study that challenges the traditional understanding of cellular metabolism, researchers at the Broad Institute...
